Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Psychosocial Support for Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
- Status
- COMPLETED
- Phase
- NA
Study of XL820 in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
- Status
- COMPLETED
- Phase
- NA
Palliative Care Study in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
- Status
- TERMINATED
- Phase
- PHASE3
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
- Status
- COMPLETED
- Phase
- NA
Bioavailability and Effectiveness of Transdermally Administered Morphine
- Status
- COMPLETED
- Phase
- PHASE1
Sublingual Methadone for the Management of Cancer Breakthrough Pain
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin Pharmacokinetic (PK) Study
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Health eCommunities - The Impact of Listservs on Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Oral AEE788 in Adults With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
- Status
- COMPLETED
- Phase
- N/A
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study to Evaluate FluMist in Immunocompromised Children
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2